InvestorsHub Logo
Followers 8
Posts 303
Boards Moderated 0
Alias Born 05/22/2020

Re: None

Thursday, 06/03/2021 10:09:07 PM

Thursday, June 03, 2021 10:09:07 PM

Post# of 232155
Open request to Cytodyn, inc Board of Directors:

Cytodyn CEO Nader Pourhassan has violated his duties in a way deserving of removal, in this shareholders view.

Being it is well known CEO Pourhassan monitors many public forums & references such in addition to shareholder e-mails received, on company conference calls, & in addition to my numerous direct attempts to Cytodyn without any confirmation, this is one forum I now choose to utilize:

CEO Pourhassan stated during the company monitored, 3rd quarter of 2020 conference call, he had chosen himself to not sell Leronlimab to certain countries. Stating: " I could make those sells right now". Followed he is choosing this due to the United States allowed him opportunities.

This shareholder believes this to have been a violation of fiduciary duties, also believed to no be covered as a Forward Looking Statement.

During May 18th, 2021 company conference call, CEO Pourhassan stated to not have received any salary during his 1st year of Cytodyn employment. In addition to this appearing not true per multiple SEC filings, and an additional fiduciary violation, this appears to demonstrate a willing to be dishonest over very extended time-frames.

One SEC filing referencing:
On August 4, 2008, the Company entered into a seven year Personal Services Agreement with Nader Pourhassan (the “Contract”). The
Contract provides for compensation to Dr. Pourhassan at an annual salary of $200,000. Additionally, as incentive compensation,Dr.Pourhassan’s personal assistant and one additional person are to receive 50,000 common shares each of Company stock for every $500,000 in capital received by the Company through Dr. Pourhassan’s efforts.

May 18th, 2021 Cytodyn conference call @ Q&A minute 53:58 when defending his current salary:

"we got nooo compensation for a year, we said we didn't want it because we make sure something
happen with this, before we get anything..."

As per SEC filings, a CEO Pourhassan personal assistants was his spouse: Mojdeh Javadi.
Mojdeh Javadi later settled suit with Cytodyn via 200k shares of Cytodyn.

In addition to the above, another event CEO Pourhassan stated on a Dr. Been July 4th, 2020 interview:

" And after studying it very carefully, we went in that path, and CytoDyn was on the brink of bankruptcy when I got it. They had $2 in the account and they had bankruptcy papers filed. It was my wife who funded it and we got back on our feet over there and then.."

This shareholder believes Cytodyn, inc has never filed for bankruptcy per state & federal court dockets.

Cytodyn of New Mexico filed a Chapter 11 bankruptcy:
Case number 07-11008, before Judge James Starzynski April 27, 2007
Bankruptcy Court District of New Mexico

Cytodyn of New Mexico & Cytodyn, inc are jointly affiliated through a Mr. Allen Allen.

CEO Pourhassan has made random references to Mr. Allen.

CEO Pourhassan is listed on Cytodyn, inc's, 2008 SEC filing with Mr. Allen & various others.
This within days of 1st joining Cytodyn.

The Cytodyn of New Mexico bankruptcy has been repeated & appears to be allowed one tail of personal embellishment(s),
but very much appears to be less than half truths by CEO Pourhassan, to this shareholder.

This shareholder believes the existence of a long term pattern of questionable character exists.

While the above is not all encompassing of concerns this shareholder has related to CEO Pourhassan's conduct, it is requested the above stated be immediately investigated & if found to be true, followed-up on with the removal of Dr. Nader Pourhassan as CEO.

Concluded with an immediate BOD search for a qualified replacement to be voted on by shareholders @ next General Meeting.

Shall Cytodyn management choose to correspond on the listed concerns,
my contact is NoMoreEcmo@gmail.com

Thank you,
Christopher.

Please note this information was provided to the internet while drafting this request.

Please include this in any BOD investigation.

Shows a May 2012 house purchase of $800k by CEO Pourhassan & spouse Mojdeh Javadi

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164196702
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News